From protocol design to real-world data, we map the 96 tech companies making clinical trials faster, cheaper, and more patient-centric.
Clinical trials are notoriously costly and lengthy. They’re also hard to recruit for: an estimated 80%+ of trials experience delays due to low patient enrollment.
As a result, a range of technologies have emerged to address issues across the entire trial lifecycle. These use AI, data analytics, and digital platforms to streamline processes, improve data quality, and boost patient engagement — all with the aim of driving down trial times and costs while increasing success rates.
This market map identifies 96 vendors in 14 categories reshaping clinical trials. This tech ecosystem offers sponsors and research organizations opportunities to conduct more efficient, patient-centric trials that also meet regulatory requirements.
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
